The 63 rating InvestorsObserver gives to Prothena Corporation PLC (PRTA) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 95 percent of stocks in the Biotechnology industry, PRTA’s 63 overall rating means the stock scores better than 63 percent of all stocks.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 63 means the stock is more attractive than 63 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Prothena Corporation PLC Stock Today?
Prothena Corporation PLC (PRTA) stock has risen 3.57% while the S&P 500 is down -0.25% as of 11:48 AM on Monday, Jun 14. PRTA has risen $1.61 from the previous closing price of $45.09 on volume of 159,942 shares. Over the past year the S&P 500 has gained 38.16% while PRTA has risen 388.49%. PRTA lost -$3.11 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Prothena Corporation PLC (PRTA) Stock.
